General 8-23 Flashcards

(53 cards)

1
Q

Rh negative and testing

A

1) Rosette: qualitative test to assess but can have false negatives
2) KB: acid elution test, with ghost cells (maternal)
3) Flow cytometry (radio labeled Ab to cells)

For increased volumes, you can give increased amount by IV, 600ug q8hours until dose is achieved.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Thyroid nodule

A

Goal is to rule out malignancy
>/= 1cm -> FNA
Other indications for FNA (if the size is smaller than 1cm) is risks for cancer such as radiation to the neck history or family history

Radionucleotide thyroid scan- hot nodule is less likely to be malignancy

Obtain TSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

General screening (non pregnancy) for DM

A

45 yo w/o risk factors, or 25 years old if BMI>25 with risk factors. Screen q3 years
Dx FBG >126 mg/dL
2hour 75g OGTT >= 200 mg/dL
random >/= 200 with symptoms
hub a1c >/= 6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Methimazole

A

Anti thyroid medication blocking t3 to t4 synthesis
Risks for fetus of aplasia cutis- :PTU [referred in the first trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cesarean delivery under local

A

0.5% lidocaine (4mg/kg) or with epinephritis (7mg/kg) (max 60cc) or w/o
O2 and EKG monitor with increased doses
midline vertical, minimal retraction?
skin. subcutaneous, viscera, parietal peritoneum
supportive care for lidocaine toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chorio treatment (during and postpartum)

A

Ampgent 2g q6h and gentamicin 1.5mg/kg q8 hour OR 5-7 mg/kg q24hour

PP: gentamicin, clindamycin 900 mg q8h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanism of ursodiol

A

increases bile flow, competes for intestinal absorption

300mg q8hou

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of glyburide

A

sulfonylurea- increase insulin sensitivity and release
max 20mg/day
1.25-2.5-5-10mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Risk of cord prolapse based on fetal presentation

A

cephalic/frank breech: 0.4-0.55
complete breech: 5%
footling breach: 15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thyroid storm

A

Admit to the ICU
1) Thioamide: PTU 100mg -> 200mg
2) Iodide (lugol’s, KI)
3) Steroids, block T4-> t3
4) B-blockers: decreased sympathetic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inflixamab

A

Anti TNF alpha, monoclonal Ab, -> q8 week dosing usually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

breast candidiasis

A

Infant should be treated by peds
topical: miconazole
oral: diflucan 400mg PO x1 -> 200mg qd for 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

KCL for cardioplegia

A

5-15cc of KCl (2meq/mL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cysto procedure

A

30 or 70 degree score (esp for trigone)
5ml of indigo carmine 10-15 min prior

Insert - identify interureteric ridge, water for efflux, remove slowly to inspect uretrha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

alpha thal types

A

aa/aa normal
a-/aa asymptomatic carrier

a-/a- (African Am/African) - mild anemia
aa/– (cis) southeast asian

a-/–HbH
–/–Hb Barts hydrops. IUFD

Chromosome 16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PPROM

A

Azithromycin 1mg PO x1
ampicillin 2g q6h -> 48 hours
amoxicillin 500mg q8h for 5 days

PCN allergic: (mild)
cefazoline 1g q8h x48 hours -0> reflex 500mg PO q6h x 5days
azithromycin 1gPO x1

PCN allergic (severe)
clindamycin 900mg q8h x 48h -> 300q8h x5da
gentamicin 7mg/kg x2 doses
azithromycin 1mg PO x1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

CMV and pregnancy:

A

0.2-2.2% of all neonates- the most common congenital infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

HSV in pregnancy
treatment and suppression
transmission risk
neonatal HSV

A

tx valtrex 100mg BID x 10 days
suppression: valtrex 500mg BID starting at 36 weeks

transmission: 1’ near delivery 30-60%
2’ with lesions 3%, w/o 2/10K
neonatal: skin/eye/mouth, CNS, worst is disseminated CNS DIC and skin. can be trans placental but much more rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

LSIL in pregnancy

A

Preferential: colposcopy in pregnancy (mostly to rule out high grade lesions or cancer)
can defer colposcopy for 6 wks PP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

types of cerclages

A

history: prior cerclage, cervical insufficiency, >/= 2 trimester losses
US: <25mm at 24 weeks (with prior history)
exam: <10mm OR cervical dilations- usually with no history of PTB
C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Classical CD indications

A

preterm- can be up to 32 weeks if the LUS is not developed (such as FGR)
dense, extensive adhesions
Fibroids
+/- transverse with back down
post-mortem c/s (for maternal death)
3-7% rupture in the next pregnancy (possibly even up to 10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Posplacental IUD

A

Ideally within 10 minutes of delivery of the placenta
20-35ry% of expulsions
Contraindications: endometritis, PAS

23
Q

Therapeutic anticoagulation
- dose antepartum
- intrapartum management

A

Lovenox 1mg/kg q12H
heparin: goal aPTT 1.5 2.5 (q12h dosing)
consider UFH at 36-37 weeks
- Lovenox d/c i 24 hours and then plan for delivery
if high risk (prosthetic heart valve, fib, PE), consider IV UFH in labor -< stopped for epidural (4-6) and before delivery

In labor:
24 hours stop Lovenox before epidural
UFH: 12 hours stopped before an epidural

Postpartum:
Resuming Lovenox dose:
4-6-12 VD
6-12 CD
Resuming UFD dose:
4-6-12 VD
12-24 CD

24
Q

Home birth

A

2-3x increased risk of neonatal death
no recommended by ACOG

25
Respiratory disease: Flu TB CPAP (PNA) Asthma
Flu: PCR testing and treatment with oseltamivir (neuramidase inhibitor) in 48 hours within for symptoms 75mg PO for 5 days TB: LTBI for 3-4 months, postpartum treatment if the CXR is negative CPAP/PNA: S. pneumo, viruses, PO2>70, IV abx with ceftriaxone, aziithromycin- avoid fluroquinolones Asthma: acute keep O2>95%, if <90%, get an ABG albuterol q20minjutes and IV methyprednisone Long term meds: Budesonide: ICS Fluticason: ICS Advairr: fluticasone + salmeterol Symbicord: budesonide + formetrol
26
cervical pregnancy or corneal pregnancy
cervical: asymmetrical distention of the cervix, US will show hourglass shaped uterus and ballooning of the cervical canal Treatment: excision of the mass, possible hysterectomy, placement of sutures, packing, UAE +/- med management but if medical management ,then needs to be managed inpatient for high risk of bleeding CORNUAL - XLAP, excision and uterine reconstruction (possible laparoscopically but will need a specialist) - NO ROOM FOR MED MANAGEMENT
27
Gardasil vaccine
Covers HPV 6, 11, 16, 18, 31, 33 45, 52, 58 (9 subtypes) Ages 9-26(female) and males 13-21) - although ages have been now extended 3 months (0, 2, 6 months) 14-16 years old- only need 2 doses 0, 6, months Covers 10% HPV related cancers, 15% of cervical cancers does NOT cover condylomata - should be treated with TCA, imiquimod
28
Molar pregnancy Imaging High risk factors for poor prognosis
Additional imaging: CT chest, pelvis, head Poor prognosis risk factors: HCG >40K before treatment >4 months from last pregnancy last pregnancy full term brain/liver mets prior chemo treatment for molar pregnancy TREATMENT a) no mets: Hysterectomy if childbearing is complete or MTX IM weekly until there are 2 negative readings b) Low risk mets: hysterectomy, single MTX +/- actinomycin c) High risk: EMA/CO treatment chemo
29
FGR delivery timing
FGR 39 weeks Severe FGR: 37 FGR with elevated UAD 37 weeks sFGR with elevated UAD 36 weeks FGR absent 33-34 FGR reversed 30-32
30
Maternal cardiac disease management - ante/intra/post
Ante: ECHO, WHO category, consultations Intra: strict I/O monitoring, L Lateral positioning, early epidural to prevent catecholamine surge with pain, +/- operative delivery, +/- telemetry Postpartum: telemetry, +/- diuresis
31
Vesicovaginal fistula- non surgical initial managemen t
Foley catheter to decompress the bladder first If there is a small or high fistulae, this may spontaneously heal with a cathether keep the catheter in for 4-6 weeks If still draining despite conservative management -> give it a longer time to 12 weeks (to wait for all suture material to dissolve) and go for OR management with 3 layer closure technique: 1) excise the fistula 2) bladder submucosa 3) bladder muscularis 4) vaginal mucosa
32
Lidocaine doses and side effects
LEEP: <10cc with 1% lidocaine c/s: 30cc of 1% w/o epi 60cc of 1% w/ api or double if 0.5% lidocaine 7mg/kg is the rough estimate side effects: metallic taste, oral numbness, tinnitus, speech changes, vision changes, AMS, seizures, arrhythmia, cardiac arrest
33
Respiratory parameters intubation in the ICU(for asthma and other respiratory conditions)
PO2 <50 Pco2 >45 Ph <7.35 maternal exhaustion altered mental status
34
steroids for mag neuroprotection
steroids: increase surfactant production max effect 2-7 days after BMZ BMZ more definitive effect on IVH improves: mortality, RDS, IVH, necrotizing enterocolitis Mag: stablizes blood pressure in the fetus and cerebral blood flow stabilized neuronal membranes 6-12 hours before birth improves: mortality, cerebral palsy
35
twin breech extraction- inclusion criteria
Twin A must be cephalic 32 -39 weeks (or 28 weeks, pending 1500g cutoff) SVD does not have higher composite risk of adverse neonatal outcomes <20% weight discordance between the twins (namely, Twin B being larger than twin 1) at least 1500mg/28 weeks Give nitro 50-200mcg for uterine relaxation for breech extraction
36
post term pregnancy
definition: >/= 42 weeks, 0.25% of pregnancy morbidity/mortalitiy - macrosomia risk - risk of dysmaturity and uteroplacental insufficiency - risk of meconium - seizures, CP, hypoglycemia mortality rate is increased by 2x
37
Fetal OP and manual rotation
AP diameter occiput to town: 9.5 (ideal) occiput to front (11.5) occiput to mentum (13.5) -> OP Occurs 25% of the time in labor, of these 80-90% will spontaneously become OA 5-12% will be born OP without any intervention (and persistence) Management: Stage 2: Nullip: 1.5-2 hours multiple: 1 hours
38
Fetal T21 and tests sen for NIPT
Extra chromosome 21 cfDNA sens 99.3%, spec 99.8% PPV: age 25: 33%, age 40 87% dysmorphia features, developmental delay findings: nuchal thickening, bowel, short humerus/femur, pyelectasis, duodenal atresia
39
IV iron dosing
10-20cc/100mL NS -> do EFM for risk of anaphylaxis 20mg Fe/ML Required iron dose (mg) = (2.4 × (target Hb-actual Hb) × pre-pregnancy weight (kg)) + 1000 mg for replenishment of stores Equations : Total body iron deficit (mg) = body weight (kg) x (target Hb – actual Hb in g/dL) x 2.4 + iron depot (mg)** [1, 2] Iron depot: 15 mg/kg for body weight less than 35 kg 500 mg for those with a body weight greater than or equal to 35 kg Ideal Body Weight (kg) =45.5 +2.3 * (height inches - 60 inches) [3]
40
SCD risks and treatment for SC crisis
Risks: PTL, PPROM, FGR, IUFD, infections, crisis, folate deficiency Crisis treatment: O2 sat >95%, IVF, pain medication (will need opioids), Hgb >10, HgA>40%, may need exchange transfusion
41
Nephrotic syndrome and pregnancy and AC
Definition: >300mg protein/day (increased dues to increased FGR) glomerular dz treatment: - immunosuppression +/- - start LDA - limit Na intake 1.5g/day - +/- AC due to low albumin Risks: PEC, thrombosis in pregnancy or postpartum
42
Vasa previa - types - % resolution - fetal blood volume - admission and delivery
Admission +/- 30 weeks Delivery at 34-35 weeks Types: I: velamentous II: bilobed III: branded out and returns (most rare) 15% may resolve by the 3TM there can be up to 60% perinatal mortality due to hemorrhage if undiagnosed Fetal blood volume: <100cc/kg clues on ultrasound: multi lobed, succenturiate, velamentous placental TVUS: FHR/doppler
43
IgA nephropathy
most common cause of primary/idiopathic/ glomerulonephritis slow progression to ESRD Risks in pregnancy: HTN, age, proteinuria, race, ACEi Tx: optimized supportive care, HTN control, RAAS.ACEI , may. need immunosuppression with high risk Types: IgA with minimal change -> usually goes into remission IgA with AKI IgA with rapidly progressive glomerulonephritis Pregnancy: usually well tolerated if not rapidly progressing
44
Rheumatic heart disease Mitral valve (bio prosthetic)
RHD - fever with group A strep (usually highest risk ages 5-15) - Sx present as JONES (2 major and 1 minor): joints, cardiac, nodules, erythema marginatum, syndeham chorea (hypotonia and movement) - cardiditis with MV damage, 10-20 years after and turns into MV stenosis - presenting symptoms: dyspnea, fib (causing thrombosis), WHO Class IV, can turn into increased L atrial pressure, dyspnea, pulmonary edema ***50% in pregnancy will progress to pulmonary edema and heart failure Tx: beta blockers diuretics AC (fib, thrombosis, prosthetic valve) Lovenox (mitral) Xa 1.0-1.2 Lovenox (aortic) Xa 0.8-1.0 UFH: 2-2.5 PTT
45
Non-OB surgery in pregnancy
optimize for 2nd trimester <24 weeks needs FHR before and after >24 hours, EFM during surgery LSC consideration Fundal height, alternative port placement, LL til, 10-15mm Hg for abdominal pressure, +/- BMZ depending on the sickness of the patient and surgery needs
46
Chronic hepatitis B
sAg +, hepbcag +, E ab (if positive- then high risk of transmission) Plan: - check VL, LFTs, GI and other hepatitis - check HIV - tenofovir 300mg -> 2x10^5 Vl copies - increased fetal risk of FGR, PtD, IUFD - Ensure there is no cirrhosis or varicose - okay for breastfeeding - HBIg +N vaccine for the newborn
47
Maternal hydrocephalus - causes management and delivery
NPH: normal pressure hydrocephalus- increased ventricular size can affect dementia, gait, incontinence and may need a VP shunt Shunt complications: 25-50% (shunt occlusion) -> enlarging uterus -> increased ICP VD +/- shorten second stage with operative delivery consult neurology
48
cardinal movements of labor
Engagement Descent Flexion Internal rotation Extension External rotation restitution expulsion
49
hidradenitis suppurativa
it is a chronic inflammatory disease of apocrine glands (pelvic, axillary) - can have a secondary bacterial infection: S aureus, s pyrogens, gram negatives - can cause extensive scarring and formation of draining sinus Treatment: Clindamycin, orał micocyclie, tetracycline steroids (intralesional) Retinoinds cyclosporine Surgical: wide local excision
50
Toxo
Toxoplasmosis - parasite from raw meat and cat feces - 1TM 10-15% transmission - 2TM 25% - 3TM: 60% or more Dx IgG /IgM Amnio PCR TX: spiramycin findings: ventriculomegaly, microcephaly, calcifications, hepatomeglaly, FGR
51
CMV
30-40% with increased tramission in the 3TM IgG/M with PCR Findings of microcephaly, chorioretinitis
52
VZV
treatment with Vz/ig FEtal findings of FGR, hydros, echogenic bowel, microcephaly
53
Fetal weights 24 28 32 36 weeks
24 - 670g 28- 1210g 32 2000g 36 2800 40 3600